Increased risk of bell palsy in patients with migraine : A nationwide cohort study

Neurology

Volumn 84, Issue 2, 2015, Pages 116-124

  Peng, Kuan Po ^a,b   Chen, Yung Tai ^b,c   Fuh, Jong Ling ^a,b   Tang, Chao Hsiun ^d   Wang, Shuu Jiun ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI CITY HOSPITAL   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID;

ADULT; AGE; ARTICLE; BELL PALSY; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; ICD-9-CM; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; NATIONAL HEALTH INSURANCE; NEUROLOGIST; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; STEROID THERAPY; TAIWAN; TENSION HEADACHE; CASE CONTROL STUDY; COMPLICATION; CROSS-SECTIONAL STUDY; MIDDLE AGED; MIGRAINE DISORDERS; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODEL;

ADULT; BELL PALSY; CASE-CONTROL STUDIES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; TAIWAN;

EID: 84925970646     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.0000000000001124     Document Type: Article

References (40)

1. Kim YH, Choi IJ, Kim HM, Ban JH, Cho CH, Ahn JH. Bilateral simultaneous facial nerve palsy: clinical analysis in seven cases. Otol Neurotol 2008;29:397-400.
2. Price T, Fife DG. Bilateral simultaneous facial nerve palsy. J Laryngol Otol 2002;116:46-48.
3. Gilden DH. Clinical practice: Bell's palsy. N Engl J Med 2004;351:1323-1331.
4. De Diego-Sastre JI, Prim-Espada MP, Fernandez- Garcia F. The epidemiology of Bell's palsy [in Spanish]. Rev Neurol 2005;41:287-290.
5. Hauser WA, Karnes WE, Annis J, Kurland LT. Incidence and prognosis of Bell's palsy in the population of Rochester, Minnesota. Mayo Clin Proc 1971;46:258-264.
6. Abiko Y, Ikeda M, Hondo R. Secretion and dynamics of herpes simplex virus in tears and saliva of patients with Bell's palsy. Otol Neurotol 2002;23:779-783.
7. Lazarini PR, Vianna MF, Alcantara MP, Scalia RA, Caiaffa Filho HH. Herpes simplex virus in the saliva of peripheral Bell's palsy patients. Braz J Otorhinolaryngol 2006;72:7-11.
8. Adour KK, Byl FM, Hilsinger RL Jr, Kahn ZM, Sheldon MI. The true nature of Bell's palsy: Analysis of 1, 000 consecutive patients. Laryngoscope 1978;88:787-801.
9. Paolino E, Granieri E, Tola MR, Panarelli MA, Carreras M. Predisposing factors in Bell's palsy: A casecontrol study. J Neurol 1985;232:363-365.
10. Wang SJ, Fuh JL, Young YH, Lu SR, Shia BC. Prevalence of migraine in Taipei, Taiwan: A population-based survey. Cephalalgia 2000;20:566-572.
11. Jensen R, Stovner LJ. Epidemiology and comorbidity of headache. Lancet Neurol 2008;7:354-361.
12. Schurks M, Rist PM, Bigal ME, Buring JE, Lipton RB, Kurth T. Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ 2009;339:b3914.
13. Lal V, Sahota P, Singh P, Gupta A, Prabhakar S. Ophthalmoplegia with migraine in adults: Is it ophthalmoplegic migraine? Headache 2009;49:838-850.
14. Chu CH, Liu CJ, Fuh JL, Shiao AS, Chen TJ, Wang SJ. Migraine is a risk factor for sudden sensorineural hearing loss: A nationwide population-based study. Cephalalgia 2013;33:80-86.
15. Zachariah J, Patel P. Facial pain with recurrent facial palsy. Headache 2003;43:700-701.
16. Russell MB, Ducros A. Sporadic and familial hemiplegic migraine: Pathophysiological mechanisms, clinical characteristics, diagnosis, and management. Lancet Neurol 2011; 10:457-470.
17. Zaproudina N, Teplov V, Nippolainen E, et al. Asynchronicity of facial blood perfusion in migraine. PLoS One 2013;8:e80189.
18. Centers for Disease Control and Prevention. International Classification of Diseases, Ninth Revision, Clinical Modification: ICD-9-CM [online]. Available at: http://www.cdc.gov/nchs/icd/icd9cm.htm Accessed May 23, 2014.
19. Cheng CL, Kao YH, Lin SJ, Lee CH, Lai ML. Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf 2011;20:236-242.
20. Wu CY, Chen YJ, Ho HJ, et al. Association between nucleoside analogues and risk of hepatitis B virus-related hepatocellular carcinoma recurrence following liver resection. JAMA 2012;308:1906-1914.
21. Austin PC. An Introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res 2011;46:399-424.
22. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383.
23. World Health Organization. The Anatomical Therapeutic Chemical Classification System [online]. Available at: http://www.who.int/classifications/atcddd/en/Accessed May 23, 2014.
24. Zhao D. Poisson regression adjustment of event rates and its macro procedure ADJ-POIS [online]. Available at: http://www2.sas.com/proceedings/sugi24/Posters/p256-24.pdf. Accessed November 11, 2013.
25. Brandenburg NA, Annegers JF. Incidence and risk factors for Bell's palsy in Laredo, Texas: 1974-1982. Neuroepidemiology 1993;12:313-325.
26. Morris AM, Deeks SL, Hill MD, et al. Annualized incidence and spectrum of illness from an outbreak investigation of Bell's palsy. Neuroepidemiology 2002;21:255-261.
27. Monini S, Lazzarino AI, Iacolucci C, Buffoni A, Barbara M. Epidemiology of Bell's palsy in an Italian Health District: Incidence and case-control study. Acta Otorhinolaryngol Ital 2010;30:198.
28. National Health Insurance Administration. The National Health Insurance Statistics [online]. Available at: http://www.nhi.gov.tw/search/search.aspx. Accessed October 18, 2013.
29. Jorg R, Milani GP, Simonetti GD, Bianchetti MG, Simonetti BG. Peripheral facial nerve palsy in severe systemic hypertension: A systematic review. Am J Hypertens 2013;26:351-356.
30. Adour K, Wingerd J, Doty HE. Prevalence of concurrent diabetes mellitus and idiopathic facial paralysis (Bell's palsy). Diabetes 1975;24:449-451.
31. Goadsby PJ, Lipton RB, Ferrari MD. Migraine: current understanding and treatment. N Engl J Med 2002;346: 257-270.
32. Carlow TJ. Oculomotor ophthalmoplegic migraine: Is it really migraine? J Neuroophthalmol 2002;22:215-221.
33. Chen PK, Wang SJ. Ophthalmoplegic migraine: migraine variant or cranial neuralgia? Cephalalgia 2012; 32:515-517.
34. Sacco S, Ricci S, Carolei A. Migraine and vascular diseases: A review of the evidence and potential implications for management. Cephalalgia 2012;32:785-795.
35. Scher AI, Terwindt GM, Picavet HS, Verschuren WM, Ferrari MD, Launer LJ. Cardiovascular risk factors and migraine: The GEM population-based study. Neurology 2005;64:614-620.
36. Kanazawa A, Haginomori S, Takamaki A, Nonaka R, Araki M, Takenaka H. Prognosis for Bell's palsy: A comparison of diabetic and nondiabetic patients. Acta Otolaryngol 2007;127:888-891.
37. Gronseth GS, Paduga R. Evidence-based guideline update: steroids and antivirals for Bell palsy: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2012;79:2209-2213.
38. Wang SJ, Fuh JL, Huang SY, et al. Diagnosis and development of screening items for migraine in neurological practice in Taiwan. J Formos Med Assoc 2008;107: 485-494.
39. Peitersen E. The natural history of Bell's palsy. Am J Otol 1982;4:107-111.
40. Liu CY, Hung YT, Chuang YL, et al. Incorporating development stratification of Taiwan townships into sampling design of large scale health interview survey. J Health Manag 2006;4:1-22.